new oral glp 1 agonist Not an April fool's prank! The small molecule GLP-1 receptor agonist, orforglipron, has been approved by the FDA under the trade name, "Foundayo." We discussed the data in a fall 2025 episode Oral GLP-1 for Weight Loss:

The peptide clears from circulation within hours, but the neuroplasticity changes it triggers persist for weeks

Daily sunscreen is important because sun exposure can make dullness and tanning return

Christofides EA

As the prevalence of thyroid diseases is rising in the general population, particularly the autoimmune ones and among women [11, 12], expanding research has addressed the influence of dietary habits on thyroid health via micronutrients, the gut microbiota, and overall dietary patterns [13,14,15,16]

tissue microarray-based immunohistochemical study

Our sublingual B12 drops bypass the digestive delays, absorbing rapidly under the tongue